Transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a feasibility study. Results at 6 and 12 months from a retrospective multi-centric study.

Transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a feasibility study. Results at 6 and 12 months from a retrospective multi-centric study.

Urotoday December 16, 2019 Urotoday reporting the multicentric study paper on SoracteLite for the management of BPH. Read the article here. Leggi tutto
Tuscany research, Golden Pegasus price for Leonardo Masotti

Tuscany research, Golden Pegasus price for Leonardo Masotti

Toscanamedianews November 3, 2019 Professor Leonardo Masotti, founder of El.En. Group and Chairman of Elesta, received yesterday the Tuscany Research Prize for his Career as Scientist from the Minister of Public Education. Congratulations from the entire Elesta team!... Leggi tutto

Please make your choiche

Please select your country/geographic area